Torys Key Planning Strategies for Healthcare M&A Transactions

The following feature piece is a guest blog submitted by David Chaikof and Peter McCague. The past year has seen a resurgence in healthcare and technology mergers and acquisitions (“M&A”) activity, both in North America and internationally. A combination of low interest rates, readily available private equity financing and a growing belief in the strengthening of [...]

Medical Technology – The Current Challenge and an Innovative Way Forward

The following feature piece is a guest blog submitted by Stephen Dibert, CEO of MEDEC. Medical progress through innovative technologies has been responsible for tremendous improvements in patient care and patient outcomes over several decades. This occurs through incremental innovations as well as the introduction of innovative, “disruptive” medical technology. The Current Challenge There is [...]

BIOTECanada’s Peter Benders on the state of the sector

What top three big-picture issues face biotech firms in Canada in the foreseeable future?  Top of the list is, of course, financing.  Even after an economically difficult year that saw global markets shy away from “risky” investments like biotech, within the industry, much scepticism remains about capital coming back.  On the one hand, we see [...]